OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

M. S. De Souza*, R. Trichavaroj, A. Schuetz, W. Chuenarom, Y. Phuang-ngem, S. Jongrakthaitae, S. Ratto-Kim, S. Nitayaphan, L. Dally, S. Rerks-Ngam, J. Tartaglia, D. Francis, N. L. Michael, R. M. Paris, J. H. Kim

*Corresponding author for this work

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Article number1742
Pages (from-to)O52
JournalRetrovirology
Volume6
Issue numberSUPPL. 3
DOIs
StatePublished - 22 Oct 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial'. Together they form a unique fingerprint.

Cite this